2018
DOI: 10.1016/j.apmr.2017.07.010
|View full text |Cite
|
Sign up to set email alerts
|

Viscosupplementation for Hip Osteoarthritis: A Systematic Review and Meta-Analysis of the Efficacy on Pain and Disability, and the Occurrence of Adverse Events

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
24
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(26 citation statements)
references
References 32 publications
1
24
0
1
Order By: Relevance
“…92 Evidence for its use in hip OA is more mixed, and although several trials have shown some benefit, a recent meta-analysis of eight randomized controlled trials showed little evidence of benefit over placebo at 3 months, with no evidence of benefit at 6 months. 93 There is a relative paucity of evidence for the use of HA in elbow OA, with a single case series reporting some benefit at 3 months. 94 HA did show positive results, however, in a randomized controlled trial for the treatment of lateral epicondylitis.…”
Section: Viscosupplementationmentioning
confidence: 99%
“…92 Evidence for its use in hip OA is more mixed, and although several trials have shown some benefit, a recent meta-analysis of eight randomized controlled trials showed little evidence of benefit over placebo at 3 months, with no evidence of benefit at 6 months. 93 There is a relative paucity of evidence for the use of HA in elbow OA, with a single case series reporting some benefit at 3 months. 94 HA did show positive results, however, in a randomized controlled trial for the treatment of lateral epicondylitis.…”
Section: Viscosupplementationmentioning
confidence: 99%
“…There was no difference at 1 month between steroid injection and viscosupplementation. 15 It is, therefore, difficult to justify the cost of viscosupplementation in the hip with the current available evidence. Regenerative therapies such as platelet-rich plasma or adipose mesenchymal stem cells have also been used.…”
Section: Nonoperative Treatmentmentioning
confidence: 99%
“…Leite и соавт. [67] выполнили метаанализ 11 РКИ (n=807), в 4 из которых ГлК сравнивалась с плацебо, в 3 -с ГК, еще в 3 -с ОТП и в 1 -с местным анестетиком (мепивакаин). В некоторых РКИ предусматривались 3 исследуемые группы (например, ГлК, ОТП и плацебо).…”
Section: рис 1 механизм действия экзогенной глкunclassified